Our observation that standard chemotherapy agents enriched the aggressive, invasive and chemo-resistant LC subpopulation in vitro, and the enhanced percentage of LCs when comparing KRT14 staining in tissues collected from HGSOC patients prior and after chemotherapy, provides a plausible explanation for the high rate of relapse and emergent drug resistance amongst ovarian cancer patients. Here, KRT14 is linked to ovarian cancer.